CTSO
Cytosorbents Corporation
NASDAQ · USHealthcareMedical - Devices
$0.38+5.58%
Price as of Jul 20, 2026
CTSO valuation
Cytosorbents Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 19.48x
- P/S forward
- 0.52x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.88x
- Price / sales
- 0.64x
- Price / cash flow
- -2.37x
Enterprise value
- Enterprise value
- $38.0M
- EV / sales
- 1.02x
- EV / EBITDA
- -4.88x
- EV / EBIT
- -2.84x
- Market cap
- $23.9M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.